Stryker to acquire fluorescence imaging tech developer Novadaq
In a definitive agreement, Stryker (Kalamazoo, MI) will acquire Novadaq Technologies (Mississauga, ON, Canada) for $701 million. Novadaq develops fluorescence imaging technology that provides surgeons with visualization of blood flow in vessels, and related tissue perfusion in cardiac, cardiovascular, gastrointestinal, plastic, microsurgical, and reconstructive procedures.
Novadaq's technology complements Stryker's advanced imaging portfolio, and expands its product offerings into open and plastic reconstructive surgery, says Timothy J. Scannell, group president, MedSurg and NeuroTechnology at Stryker. The technology can reduce post-procedure complication rates and the cost of care for a broad variety of surgical treatments, he adds.
The transaction is expected to close at the end of the third quarter of 2017.
For more information, please visit www.stryker.com and http://novadaq.com.
BioOptics World Editors
We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)